NRI Dr. Jayam Krishna Iyer, Florida faces a 10-20 years in federal prison for medicare fraud & prescribing narcotics
TAMPA, September 21, 2018
NRIpress.club/Ramesh/Gary Singh Grewal
NRI Pain doctor, Jayam Krishna Iyer, 66, form Clearwater, Florida, admitted to criminal wrongdoing in court, pleaded guilty to Medicare fraud and also agreed to give up her license to practice medicine.
Since 2000, FBI, Justice Department, Health and Human Services and narcotics bureau have been investigating allegations of illegal pain prescriptions and Medicare fraud against Iyer.
In 2018, the case was investigated by the Opioid Fraud and Abuse "to help combat the devastating opioid crisis that is raving families and communities across America," according to a statement from the U.S. Attorney's General Jeff Session. The Florida Attorney General Medicare Fraud Control Unit, The FBI, Department of Health and Human Services Office of the Inspector General, DEA were all involved in the investigation.
Florida records show that Dr. Iyer agreed to forfeit her medical licenses after an unrelated investigation of overmedicating patients and illegal prescriptions launched six years ago by the Florida Department of Health.
Dr. Iyer signed an agreement on Aug 31, 2018 with federal prosecutors in Tampa that she submitted at least USD 51,500 in these types of false and fraudulent Medicare claims under Creative Medical Centre, a pain management clinic located at Druid Road East in Florida's Clearwater area.
Registrant Actions - 2009
Jayam Krishna-Iyer, M.D.; Suspension of Registration; Granting of Renewal Application Subject to Condition:
In 2006, the Deputy Administrator of the Drug Enforcement Administration, ordered that the DEA Certificate of Registration issued to Jayam Krishna-Iyer, M.D. (Respondent), of Clearwater, Florida, be revoked-Jayam Krishna-Iyer, M.D., 71 FR 52148, 52159 (2006).
The Order also denied Respondent's pending application for renewal of her registration. DEA noted that Respondent had issued prescriptions for controlled substances to three separate undercover operatives notwithstanding that each of the operatives had indicated that he was not in pain, and had told Respondent that he was obtaining controlled substances from non-legitimate sources such as friends.
Respondent filed a petition for review in the U.S. Court of Appeals for the Eleventh Circuit. On September 25, 2007, following briefing and oral argument, the Court vacated the Agency's Order in an unpublished opinion.
She Acknowledged wrongdoing for failing to conduct physical examinations of the three undercover patients in this case"; (2) "acknowledge[d] wrongdoing for improperly indicating on the charts of the undercover patients that she had conducted a physical examination of" them; and (3) "acknowledge[d] that she had presigned various prescriptions and understands that this was improper." Respondent's Statement at 1. Respondent also apologized for her conduct with respect to each of the above actions and promises that she will not engage in similar conduct in the future. further order that the application of Jayam Krishna-Iyer, M.D., for renewal of her registration be, and it hereby is, granted subject to the condition that she file monthly reports with the Special Agent in Charge
Another way people will try to amplify an OxyContin high is by mixing it with other substances. One of the substances most commonly mixed with OxyContin is alcohol. When someone takes these substances together, it can increase the pleasurable high, but it’s also incredibly dangerous or fatal.
If someone takes this prescription drug as directed for pain, there isn’t usually an OxyContin high that comes with it, particularly since it is controlled-release. In general, people who truly do have severe pain don’t tend to feel high when they take opioids, and this is especially true with OxyContin because it is an extended release drug.
For starters, guidelines for prescribing opioids to treat chronic pain have been issued by the Center for Disease Control and Prevention (CDC). This is an effort to encourage doctors to prescribe pain medications responsibly.
In 1994, Purdue Pharma started testing the use of its medicine Oxycontin as a long-term painkiller. It was in 1996 when it went on the market.The number of painkiller prescriptions increased rapidly from the early to mid-1990s, when it jumped from 2-3 million each year to 8 million. Along with the increased in sales was the number of individuals who were slowly getting hooked on this drug.
Over the years, oxycodone became popular among patients suffering from chronic pain.Some individuals began to abuse this prescription drug. This is the reason why Oxycontin is referred to as a “wonder drug” that turned to be an “epidemic drug”.
According to the 2013 National Survey on Drug Use and Health, close to 10 percent among individuals 18-25 years old have abused Oxycontin. According to Business Week, a stream of privately owned pain management clinics in Florida was reported to have sold $40 million dollars worth of oxycodone pills in a matter of two years. Withdrawal symptoms can be extremely uncomfortable. This may often result in getting back into the habit of the user, just to avoid the symptoms.
The CSA requires that controlled substances be prescribed, dispensed or administered only for legitimate medical purposes by practitioners acting in the usual course of their professional practice. The CSA and its implementing regulations do not define "legitimate medical purpose" nor do they set standards as to what constitutes "the usual course of professional practice." DEA relies on the medical community to make these determinations. DEA has a well-established relationship with experts in the field of pain management and has enlisted their expertise in devising strategies to ensure that OxyContin® and other powerful opioids are appropriately prescribed.
Schedule II opioids are best used as the treatment of last resort for chronic pain; and that when they are used, they should be part of a multi-disciplinary approach to pain management, including physical and psychological therapy. DEA has strongly supported the establishment of "Model Guidelines for the Use of Controlled Substances in Pain Management" by the Federation of State Medical Boards.
Jayam Krishna Iyer, M.D recieved Board Certification in Anesthesiology, Pain Management, Medical Acupuncture, Homeopathy and Critical Care and Board Certified Medical Doctor in her own private practice since 1984. Board Certified Medical Doctor in her own private practice since 1984.She started her Aesthetic training in 2008 with Empire Medical Academy for 2 years and received certification in the following services and proceduce Board Certified Medical Doctor in her own private practice since 1984 incuding Dermatology Procedures, Cosmetic Laser Workshop, Anti Aging and Integrative Hormone, Sclerotherapy & Laser Solutions, Cosmetic Laser Workshop, Weight Loss Management & Treatment, Comprehensive Facial Aesthetics Programs, Comprehensive Dermal Filler Program, Comprehensive Botox Program.
Professional Memberships: American Society Of Anesthesiology; Society For Ambulatory Anesthesiologists; American Academy Of Pain Management; American Society Of Clinical Hypnosis; American Pain Society; American Academy Of Medical Acupuncture
Medical Licenses- Florida, Pennsylvania; Licensed In India,and France